Skip to main content
padlock icon - secure page this page is secure

Free Content Fluvoxamine as a Cause of Stimulation, Mania, and Aggression: A Critical Analysis of the FDA-Approved Label

Download Article:
(PDF 1,251.3 kb)
The contents of the FDA-approved label for Luvox (fluvoxamine) are compared to the known risks of fluvoxamine-induced stimulation, mania, and aggression in children and adults. It is found that the label in many ways fails to communicate the severity and range of these drug-induced adverse mental and behavioral drug effects. Health professionals need to approach government-approved labels with skepticism and scientific sophistication, especially in regard to evaluating the risks of medications.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Journal Article

Affiliations: Ithaca, NY

Publication date: January 1, 2002

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more